Calcium Folinate



Indications and Reactions:

Role Indications Reactions
Primary
Colorectal Cancer Metastatic 20.2%
Metastatic Colorectal Cancer 12.1%
Product Used For Unknown Indication 11.0%
Colon Cancer 8.1%
Drug Use For Unknown Indication 6.9%
Chemotherapy 4.6%
Colorectal Cancer 4.6%
Pancreatic Carcinoma 4.6%
Rectal Cancer 4.0%
Adenocarcinoma Of Colon 3.5%
Colon Cancer Metastatic 3.5%
Metastatic Carcinoma Of The Bladder 2.9%
Prophylaxis Of Nausea And Vomiting 2.9%
Metastases To Liver 2.3%
Metastatic Colon Cancer 1.7%
Neoplasm Malignant 1.7%
Stomach Cancer 1.7%
Candida Infection 1.2%
Colon Cancer Stage Iii 1.2%
Gastric Cancer Stage Iv 1.2%
Pyrexia 15.6%
Paraesthesia 9.4%
Interstitial Lung Disease 6.3%
Liver Injury 6.3%
Respiratory Failure 6.3%
Thrombocytopenia 6.3%
Urinary Tract Infection 6.3%
Vomiting 6.3%
Anaemia 3.1%
Cardiovascular Disorder 3.1%
Confusional State 3.1%
Deep Vein Thrombosis 3.1%
Device Related Infection 3.1%
Drug Interaction 3.1%
Extravasation 3.1%
Febrile Neutropenia 3.1%
General Physical Health Deterioration 3.1%
Hepatitis B 3.1%
Hypersensitivity 3.1%
Hypotension 3.1%
Secondary
Colon Cancer 29.7%
Colorectal Cancer 19.3%
Colorectal Cancer Metastatic 12.7%
Lymphoma 8.8%
Prophylaxis 6.0%
Rectal Cancer 3.8%
Hypertension 2.8%
Adenocarcinoma 2.1%
Drug Use For Unknown Indication 1.6%
Product Used For Unknown Indication 1.5%
Vomiting 1.5%
Folate Deficiency 1.4%
Pancreatic Carcinoma 1.3%
Pain 1.2%
Prophylaxis Of Nausea And Vomiting 1.2%
Constipation 1.2%
Premedication 1.1%
Colon Cancer Metastatic 1.1%
B-cell Lymphoma 0.9%
Breast Cancer Metastatic 0.9%
Disease Progression 13.8%
Vomiting 11.6%
Death 7.5%
Intestinal Obstruction 6.7%
Pulmonary Embolism 6.3%
Erythrosis 6.0%
Neutropenia 4.9%
Pyrexia 4.9%
Tachycardia Paroxysmal 4.5%
Thrombocytopenia 4.5%
Anal Abscess 3.4%
Diarrhoea 3.4%
Respiratory Failure 3.4%
General Physical Health Deterioration 3.0%
Jugular Vein Thrombosis 3.0%
Neurotoxicity 3.0%
Electrocardiogram St Segment Depression 2.6%
Epistaxis 2.6%
Hypovolaemia 2.6%
Nervous System Disorder 2.6%
Concomitant
Drug Use For Unknown Indication 20.0%
Rheumatoid Arthritis 10.6%
Product Used For Unknown Indication 9.4%
Colon Cancer 7.8%
Hiv Infection 6.7%
Prophylaxis 6.0%
Premedication 5.4%
Colorectal Cancer Metastatic 5.0%
Hypertension 4.6%
Rectal Cancer 4.0%
Acute Lymphocytic Leukaemia 3.0%
Infection 2.6%
Central Nervous System Lymphoma 2.4%
Cerebral Toxoplasmosis 2.2%
Colon Cancer Metastatic 2.1%
Infection Prophylaxis 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.8%
Bone Marrow Conditioning Regimen 1.7%
Prophylaxis Against Graft Versus Host Disease 1.6%
Colorectal Cancer 1.4%
Thrombocytopenia 9.7%
White Blood Cell Count Decreased 9.0%
Renal Failure Acute 7.6%
Pyrexia 6.9%
Sepsis 6.2%
Pyothorax 5.5%
Vomiting 5.5%
Muscular Weakness 4.8%
Diarrhoea 4.1%
Neuroendocrine Carcinoma 4.1%
Rash 4.1%
Septic Shock 4.1%
Stomatitis 4.1%
Urticaria 4.1%
Crohn's Disease 3.4%
Myocardial Infarction 3.4%
Pulmonary Embolism 3.4%
Rectal Haemorrhage 3.4%
White Blood Cell Count Increased 3.4%
Dyspnoea 2.8%
Interacting
Drug Use For Unknown Indication 38.9%
Rectal Cancer 33.3%
Colorectal Cancer Metastatic 16.7%
Premedication 11.1%
Lower Limb Fracture 75.0%
Transaminases Increased 25.0%